Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20126164 | 0.91 | ALDH1A1 (0.41) | KDM1A | |
| SCHEMBL16749047 | 0.80 | KDM1A (0.39) | ESR2KDM1A | |
| SCHEMBL20126156 | 0.78 | — | — | |
| SCHEMBL16749046 | 0.78 | KDM1A (0.42) | ESR2KDM1A | |
| SCHEMBL2721633 | 0.74 | ESR2 (0.57) | ESR2KDM1A | |
| SCHEMBL22269082 | 0.73 | ALDH1A1 (0.51) | KDM1A | |
| SCHEMBL17931282 | 0.72 | ESR2 (0.40) | ESR2KDM1A | |
| SCHEMBL25216280 | 0.72 | CSF1R (0.37) | — | |
| SCHEMBL16749144 | 0.71 | ALDH1A1 (0.38) | KDM1A | |
| SCHEMBL20126171 | 0.71 | SPHK1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160289189-A1 | PIPERIDINE DERIVATIVE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC CORPORATION (JP) | 2016-10-06 | — | — | US | disclosed |
| US-20160289189-A1 | PIPERIDINE DERIVATIVE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC CORPORATION (JP) | 2016-10-06 | — | — | US | disclosed |
| EP-3072885-A1 | PIPERIDINE DERIVATIVE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC Corporation (JP) | 2016-09-28 | — | — | EP | disclosed |
| WO-2015076077-A1 | PIPERIDINE DERIVATIVE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC株式会社 | 2015-05-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160289189-A1 | PIPERIDINE DERIVATIVE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | PLD1, DRD1, CCND1 | ESR2 2607/4885KDM1A 635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.